SCHEMBL4280485

SCHEMBL4280485

CCC(=O)N1CCC(c2ccccc2)(N2CCN(C)CC2)CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 5/20 0.57
LMNA P02545 2/20 0.48
BLM P54132 1/20 0.48
OPRD1 P41143 3/20 0.46
SLC6A4 P31645 2/20 0.45
KCNH2 Q12809 2/20 0.45
SLC22A1 O15245 1/20 0.45
ADRA1A P35348 1/20 0.45
OPRK1 P41145 1/20 0.45
SIGMAR1 Q99720 2/20 0.44
GRIN2D O15399 1/20 0.42
GRIN3B O60391 1/20 0.42
CYP2B6 P20813 1/20 0.42
SLC6A2 P23975 1/20 0.42
PRCP P42785 1/20 0.42
SLC6A3 Q01959 1/20 0.42
GRIN1 Q05586 1/20 0.42
GRIN2A Q12879 1/20 0.42
GRIN2B Q13224 1/20 0.42
GRIN2C Q14957 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4283594 0.87 SMN1; SMN2 (0.47) OPRM1LMNAEPHX2
SCHEMBL4273032 0.85 MAPK1 (0.46) OPRM1LMNASLC6A2EPHX2
SCHEMBL4276599 0.82 CYP2C9 (0.49) OPRM1OPRD1
SCHEMBL14279640 0.81 SLC6A4 (0.56) OPRM1OPRD1SLC6A4KCNH2SLC22A1
SCHEMBL4280380 0.77 OPRM1 (0.47) OPRM1LMNABLMOPRD1SIGMAR1
SCHEMBL18793811 0.77 OPRM1 (0.66) OPRM1LMNABLMOPRD1SLC6A4
SCHEMBL10760411 0.77 OPRM1 (0.66) OPRM1LMNABLMOPRD1OPRK1
SCHEMBL18068774 0.74 OPRM1 (0.62) OPRM1LMNABLMOPRD1SLC6A4
SCHEMBL4276385 0.74 OPRM1 (0.62) OPRM1LMNABLMOPRD1OPRK1
SCHEMBL14304640 0.73 TSHR (0.48) OPRM1OPRD1SLC6A4KCNH2SLC22A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090253669-A1 Substituted Sulfonamide Compounds GRUENENTHAL GMBH (DE) 2009-10-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090253669-A1 Substituted Sulfonamide Compounds SULT2A1, STS, SULT1A1 OPRM1 2798/4885LMNA 2546/4885BLM 4144/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.